Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
A phase 2 trial of Atirmociclib, Letrozole, Fulvestrant in prostate cancer, run by Pfizer, active and no longer recruiting.
Overview
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors is a phase 2 interventional study registered as NCT04557449 by Pfizer, with 362 participants enrolled, started 2020-09-23 and due to reach its primary completion in 2026-09-23. Interventions recorded: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide. Conditions listed: Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
Shares Atirmociclib, Fulvestrant, Pfizer (incl. Seagen).
- TrialStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
Shares Atirmociclib, Letrozole (and other aromatase inhibitors), Fulvestrant, Pfizer (incl. Seagen).
- TrialStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Shares Letrozole (and other aromatase inhibitors), Fulvestrant, Prostate cancer.
- TrialPF-07104091 as a Single Agent and in Combination Therapy
Shares Letrozole (and other aromatase inhibitors), Fulvestrant, Pfizer (incl. Seagen).
- TrialA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Shares Enzalutamide, Pfizer (incl. Seagen), Prostate cancer.
- TrialThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking En
Shares Enzalutamide, Pfizer (incl. Seagen), Prostate cancer.
- TrialStudy of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Shares Enzalutamide, Pfizer (incl. Seagen), Prostate cancer.
- TrialA Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
Shares Atirmociclib, Pfizer (incl. Seagen).